📰 Phase 3 Studies News
Phase 3 Studies News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Phase 3 Studies. Real-time updates on events, politics, business and more.
April 11, 2023
Closing out this discussion, experts share their final thoughts on advanced HCC treatments and key data presented at the 2023 ASCO Gastrointestinal Cancers Symposium.
March 27, 2023
Expert panelists highlight anti-angiogenic systemic therapies under investigation for advanced HCC in second line and beyond.
March 27, 2023
In the context of frontline treatment strategies in advanced HCC, expert oncologists review clinical research in systemic immunotherapy approaches.
June 11, 2021
– Company Expects to File for Regulatory Approval for Mitapivat for the Treatment of Adults with PK Deficiency in the U.S. This Quarter and in the EU in Mid-2021 – – Agios to Host Investor Webcast Today at 7:30 a.m. ET – CAMBRIDGE, Mass., June 11, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat genetically defined diseases, today reported a full analysis of updated data, including patient-repor...